The Association of Clinical Research Professionals

Workforce Innovation Steering Committee

The ACRP ‘Workforce Innovation Steering Committee’ (WISC) provides a unique, high-profile opportunity for organizations to partner with ACRP and provide insight and advice on the areas in need of standardization, innovation, or solutions designed to prepare the clinical research workforce to respond to the changing professional requirements resulting from industry change.

Organizations supporting the WISC receive:

  • High-profile recognition as an industry thought leader.
  • Promotion on ACRP’s website and marketing materials as a Workforce Innovation Steering Committee supporter and advocate for workforce sustainability.

 

WISC Publications

 

Why the WISC is Important…

“In clinical research, people are everything.” This is what we believe.

Workforce planning, development, and assessment is imperative to the existence, quality, and efficiency of clinical research. Yet, it has been largely overlooked as industry focuses instead on the important initiatives to improve quality and efficiency through process and technology innovation.

Clinical trials continue to increase in both volume and complexity. At the same time, pharmaceutical and medical device companies are responding to demand for lower-cost, more-efficient clinical trials by radically shifting the ways in which clinical research is conducted, adding additional pressure to an already stressed ecosystem.

The lack of focus on a standardized, industry-wide approach to workforce planning, development, and assessment is already showing symptoms of a greater disease, including:

  • Clinical research coordinator (CRC) “burnout” and low levels of job satisfaction resulting from a lack of standard methods for identifying new CRCs and providing them with training and development resources.
  • A critical shortage of clinical trial monitors/clinical research associates (CRA) and the proliferation of falsified CRA resumes.
  • Continued negative FDA inspection findings.

Industry’s current approach to workforce planning, development, and assessment is not sustainable and is not resulting in improved clinical trial outcomes. It must be a priority today to ensure the stability of the clinical research enterprise in the future and the continued development of new drugs, devices, and therapies.

In response to this critical challenge, ACRP is bringing together this new coalition of stakeholders with a vested interest in developing and promoting the needed workforce standards to improve quality and respond to changes occurring in the clinical research enterprise.